Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2356 | 2203 | 42.7 | 78% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C 11RACLOPRIDE | Author keyword | 58 | 62% | 3% | 60 |
2 | C 11FLB 457 | Author keyword | 52 | 87% | 1% | 26 |
3 | F 18 FALLYPRIDE | Author keyword | 38 | 93% | 1% | 14 |
4 | EPIDEPRIDE | Author keyword | 27 | 78% | 1% | 18 |
5 | C 11MNPA | Author keyword | 26 | 100% | 0% | 11 |
6 | C 11 RACLOPRIDE | Author keyword | 26 | 63% | 1% | 26 |
7 | FALLYPRIDE | Author keyword | 25 | 70% | 1% | 21 |
8 | RACLOPRIDE | Author keyword | 25 | 23% | 4% | 95 |
9 | F 18FALLYPRIDE | Author keyword | 21 | 75% | 1% | 15 |
10 | DOPAMINE D 2 RECEPTOR OCCUPANCY | Author keyword | 17 | 72% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C 11RACLOPRIDE | 58 | 62% | 3% | 60 | Search C+11RACLOPRIDE | Search C+11RACLOPRIDE |
2 | C 11FLB 457 | 52 | 87% | 1% | 26 | Search C+11FLB+457 | Search C+11FLB+457 |
3 | F 18 FALLYPRIDE | 38 | 93% | 1% | 14 | Search F+18+FALLYPRIDE | Search F+18+FALLYPRIDE |
4 | EPIDEPRIDE | 27 | 78% | 1% | 18 | Search EPIDEPRIDE | Search EPIDEPRIDE |
5 | C 11MNPA | 26 | 100% | 0% | 11 | Search C+11MNPA | Search C+11MNPA |
6 | C 11 RACLOPRIDE | 26 | 63% | 1% | 26 | Search C+11+RACLOPRIDE | Search C+11+RACLOPRIDE |
7 | FALLYPRIDE | 25 | 70% | 1% | 21 | Search FALLYPRIDE | Search FALLYPRIDE |
8 | RACLOPRIDE | 25 | 23% | 4% | 95 | Search RACLOPRIDE | Search RACLOPRIDE |
9 | F 18FALLYPRIDE | 21 | 75% | 1% | 15 | Search F+18FALLYPRIDE | Search F+18FALLYPRIDE |
10 | DOPAMINE D 2 RECEPTOR OCCUPANCY | 17 | 72% | 1% | 13 | Search DOPAMINE+D+2+RECEPTOR+OCCUPANCY | Search DOPAMINE+D+2+RECEPTOR+OCCUPANCY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | C 11 RACLOPRIDE | 133 | 46% | 10% | 215 |
2 | C 11 RACLOPRIDE BINDING | 125 | 74% | 4% | 93 |
3 | LIVING HUMAN BRAIN | 93 | 40% | 8% | 180 |
4 | H 3 RACLOPRIDE | 93 | 63% | 4% | 95 |
5 | ENDOGENOUS DOPAMINE | 75 | 34% | 8% | 181 |
6 | DOUBLE BLIND PET | 57 | 59% | 3% | 65 |
7 | I 125 EPIDEPRIDE | 54 | 71% | 2% | 44 |
8 | HIGH AFFINITY STATE | 53 | 64% | 2% | 52 |
9 | F 18 FALLYPRIDE | 40 | 71% | 1% | 32 |
10 | EXTRASTRIATAL D 2 DOPAMINE RECEPTORS | 38 | 93% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Consensus nomenclature for in vivo imaging of reversibly binding radioligands | 2007 | 537 | 11 | 91% |
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment | 2012 | 123 | 100 | 78% |
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway | 2009 | 563 | 142 | 34% |
The dopamine theory of addiction: 40 years of highs and lows | 2015 | 4 | 121 | 49% |
Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia | 2011 | 51 | 85 | 67% |
Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review | 2000 | 564 | 184 | 54% |
Atypical antipsychotics: Mechanism of action | 2002 | 403 | 50 | 58% |
Does fast dissociation from the dopamine D-2 receptor explain the action of atypical antipsychotics?: A new hypothesis | 2001 | 611 | 67 | 31% |
Imaging dopamine's role in drug abuse and addiction | 2009 | 252 | 79 | 32% |
Half a century of antipsychotics and still a central role for dopamine D-2 receptors | 2003 | 297 | 74 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIVIAN RAKOFF POSITRON EMISS TOMOG UNIT | 11 | 100% | 0.3% | 6 |
2 | PSYCHIAT IMAGING GRP | 9 | 64% | 0.4% | 9 |
3 | MOL NEUROIMAGING GRP | 6 | 35% | 0.6% | 14 |
4 | CLIN NEUROIMAGING TEAM | 5 | 60% | 0.3% | 6 |
5 | IZOPHRENIA CONTINUING CARE | 4 | 67% | 0.2% | 4 |
6 | INDIANA UNIV NEUROIMAGING | 4 | 75% | 0.1% | 3 |
7 | IZOPHRENIA COGNIT DISORDER DISCOVERY PERFORM | 4 | 75% | 0.1% | 3 |
8 | SECT NEUROCHEM IMAGING | 4 | 50% | 0.3% | 6 |
9 | UNIT 1039 | 4 | 75% | 0.1% | 3 |
10 | GERIATR MENTAL HLTH PROGRAM | 4 | 18% | 0.9% | 20 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000190255 | DOPAMINE TRANSPORTER//DOPAMINE TRANSPORTER IMAGING//I 123 FP CIT |
2 | 0.0000185481 | MPPF//F 18ALTANSERIN//F 18MPPF |
3 | 0.0000171032 | SEROTONIN TRANSPORTER//4 F 18 ADAM//I 123 ADAM |
4 | 0.0000169921 | FP TZTP//IQNP//DEXETIMIDE |
5 | 0.0000131518 | REMOXIPRIDE//DA D2 RECEPTORS//DOPAMINE D 2 ANTAGONISTS |
6 | 0.0000104313 | IMAGE DERIVED INPUT FUNCTION//INPUT FUNCTION//BIOMED MULTIMEDIA INFORMAT TECHNOL GRP |
7 | 0.0000100658 | CARBON 11//C 11CARBON MONOXIDE//C 11METHYL IODIDE |
8 | 0.0000088812 | DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT |
9 | 0.0000077416 | SCH 39166//DIHYDREXIDINE//DOPAMINE D1 RECEPTORS |
10 | 0.0000075859 | ARIPIPRAZOLE//ASENAPINE//ILOPERIDONE |